Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 76 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer				Phase IV				A0081128 NCT00381095
	Effect of Eszopiclone on Sleep Disturbance & Pain in Cancer				Phase IV				UCSD 060340 ESRC 054, NCT00365261
	Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression				Phase IV				1011 NCT00634426
	Symptom Management After Breast Cancer Surgery				Phase IV				Breast Pain CA107091, NCT00686127
	Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.				Phase III				EN3267-005 NCT00262678
	Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients				Phase III				EN3267-007 NCT00263575
	Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer				Phase III				RTOG-0517 RTOG 0517, NCT00365105
	Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer				Phase III				URCC-0605 URCC-07004, URCC-06-05, NCT00471445
	Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioid Therapy				Phase III				CPO45/06/FCNS NCT00458510
	Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids				Phase III				CPO43/06/FCNS NCT00459277


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute